Examples of using Post-dose in English and their translations into German
{-}
-
Medicine
-
Colloquial
-
Official
-
Ecclesiastic
-
Financial
-
Ecclesiastic
-
Political
-
Computer
-
Programming
-
Official/political
-
Political
Weighted Mean Serial FEV1 over 0-24 hours post-dose.
The total exposure up to 24 h post-dose is 124 mg*h/l in children and adolescents and 135 mg*h/l in adult patients.
Eslicarbazepine tmax is attained at 2 to 3 hours post-dose.
Post-dose is equivalent to Cmax post-dose samples were drawn 1- 3 hours after edoxaban administration.
Mcg/ ml,with a flomax and bloating concentration come in 5 inmates post-dose.
Low concentrations of sugammadex aredetectable for at least 48 hours post-dose in patients with severe renal insufficiency.
Median peak plasma concentration ofGS-331007 was observed 3 hours post-dose.
The ratios were time dependent with values decreasing gradually beyond 24 h post-dose, indicating that netupitant is being rapidly metabolized.
Following subcutaneous injection, serum levels of epoetinalfa reach a peak between 12 and 18 hours post-dose.
In addition, concentrations of radiolabeled material at 24 hours post-dose were minimal in all other tissues.
Reversal of both the microscopic and functional effects was complete within 6 months post-dose.
At all post-dose time points on day 8, the mean changes from baseline in QTcF interval were 4 -6 msec, with associated upper 95% confidence intervals< 7 msec.
Elimination via both routes was estimated to be complete by Day 29-30 post-dose.
Uroflowmetric fibers were lighted at contours of buy mestinon soft tabs(2 post-dose malignations) and/ or vesiculitis(24 salicylates post-dose) doripenem accidentes of cardura.
It can be expectedthat normally under fasting conditions gastric emptying of a formulation has taken place 30 minutes post-dose.
Tmax was reused temporarily between 6 and 10 rayos post-dose, snapping a missed abortion cytotec in dejan rate triturated with immediate-release formulations.
The effect of the combination on the patient's QTc interval should be evaluated with pre- and post-dose ECGs.
Measurements of blood pressure 24 hours post-dose relative to 5- 6 hours post-dose demonstrated blood pressure reduction over 24 hours; the natural diurnal rhythm was retained.
Patients receiving BRINAVESS havea higher incidence of converting to atrial flutter within the first 2 hours post-dose.
Incruse demonstrated a greater improvementfrom baseline in weighted mean FEV1 over 0-6 hours post-dose at Week 24 compared with placebo(150 ml, p< 0.001*) in the 24-week pivotal study.
Following subcutaneous administration of peginterferon beta-1a in multiple sclerosis patients,the peak concentration was reached between 1 to 1.5 days post-dose.
Of the patients who did not convert to sinus rhythm,the incidence of bradycardia events in the first 2 hours post-dose was similar in placebo and vernakalant treated groups 4.0% and 3.8%.
When administered by the subcutaneous or intramuscular routes, serum levels of interferon beta remain low,but are still measurable up to 12 to 24 hours post-dose.
In the active-controlled study, at least 89% of patients had P. aeruginosa isolates with MICs atleast 15 times lower than mean post-dose sputum concentration, both at baseline and at the end of the third active treatment cycle.
Table 6: Comparative analysis between 7-valent Prevenar and Synflorix in percentage of subjects withantibody concentrations> 0.20 µg/ml one month post-dose 3.
Mean increases from baseline in functional C1inhibitor activity measured 1 hour post-dose in children 2 to< 18 years of age ranged from 20% to 88% in Study LEVP 2006-1(treatment) and from 22% to 46% in Study LEVP 2006-4(prevention) compared with 21% to 66% and 25% to 32% in adults, respectively.
In the Phase 3 placebo-controlled study in patients with PAH, a transient increase in mean heartrate of 3-4 bpm at 2-4 hours post-dose was observed.
Pharmacokinetic parameters of ALPROLIX were determined for adolescents in study I(pharmacokinetic sampling was conducted pre-dose followed by assessment at multiple time points up to 336 hours(14 days) post-dose) and for children in study II pharmacokinetic sampling was conducted pre-dose followed by assessment at 7 time points up to 168 hours(7 days) post-dose.
Pharmacokinetic analyses based on multiple myeloma studies indicate that lenalidomide is rapidly absorbed at all dose levels,with maximum plasma concentrations occurring between 0.5 and 4.0 hours post-dose both on Days 1 and 28.
Atrial fibrillation patients receiving BRINAVESShave a higher incidence of converting to atrial flutter within the first 2 hours post-dose 10% versus 2.5% in placebo.